Librela

Librela injection for dogs is a monoclonal antibody treatment used to alleviate pain associated with osteoarthritis. It targets and neutralises nerve growth factor (NGF), providing long-term pain relief and improving mobility.

What is Librela for Dogs?

Librela is a breakthrough veterinary medicine designed to manage pain and inflammation associated with osteoarthritis (OA) in dogs. Unlike traditional pain relief options such as NSAIDs, which block inflammation chemicals temporarily, Librela for dogs contains bedinvetmab, a monoclonal antibody that specifically targets and neutralises nerve growth factor (NGF), one of the key proteins responsible for transmitting pain signals. By blocking NGF, Librela provides precise, long-lasting relief from joint pain without overloading the liver or kidneys.

Administered as a monthly injection, Librela helps dogs regain mobility, comfort and quality of life by reducing stiffness and improving ease of movement. Whether your dog is exhibiting early signs of osteoarthritis or managing long-term joint disease, this vet-prescribed treatment provides targeted, science-driven relief that’s gentle on the body.

Librela Injection for Dogs

Librela injection is administered under the skin (subcutaneously) once a month. The formula provides continuous relief between doses and can be used safely alongside other supportive treatments such as joint supplements or physiotherapy.

Librela Dose

Your vet will determine the correct dose based on your dog’s weight. At Pet Drugs Online, the following Librela injection for dogs strengths are available:

• Librela 5mg – for dogs weighing 5–10kg

• Librela 10mg – for dogs weighing 10.1–20kg

• Librela 15mg – for dogs weighing 20.1–30kg

• Librela 20mg – for dogs weighing 30.1–40kg

• Librela 30mg – for dogs weighing 40.1–60kg

Each strength is designed to deliver consistent, tailored pain management suited to your dog’s size and needs.

FAQs